Search details
1.
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis.
J Transl Med
; 19(1): 132, 2021 03 31.
Article
in English
| MEDLINE | ID: mdl-33789686
2.
Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
Anticancer Drugs
; 30(3): 308-312, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30779722
3.
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
BMC Cancer
; 16(1): 918, 2016 11 25.
Article
in English
| MEDLINE | ID: mdl-27884140
4.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Lancet Oncol
; 16(5): 583-94, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25892145
5.
Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.
Oncology
; 89(3): 125-36, 2015.
Article
in English
| MEDLINE | ID: mdl-25967534
6.
Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study.
Oncology
; 84(4): 251-4, 2013.
Article
in English
| MEDLINE | ID: mdl-23428719
7.
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review.
Cancers (Basel)
; 14(15)2022 Jul 22.
Article
in English
| MEDLINE | ID: mdl-35892820
8.
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
Cells
; 11(19)2022 10 10.
Article
in English
| MEDLINE | ID: mdl-36231138
9.
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.
Diagnostics (Basel)
; 11(6)2021 May 28.
Article
in English
| MEDLINE | ID: mdl-34071518
10.
Patients affected by squamous cell carcinoma of the head and neck: A population particularly prone to developing severe forms of COVID-19.
Exp Ther Med
; 22(5): 1298, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34630653
11.
Treatment approaches to nasopharyngeal carcinoma: a review.
Anticancer Drugs
; 21(5): 471-7, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20124988
12.
Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat.
Cancers (Basel)
; 12(4)2020 Apr 15.
Article
in English
| MEDLINE | ID: mdl-32326465
13.
Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.
Transl Oncol
; 13(2): 262-274, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31869751
14.
Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
Cancers (Basel)
; 12(10)2020 Sep 28.
Article
in English
| MEDLINE | ID: mdl-32998297
15.
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Front Cell Dev Biol
; 8: 732, 2020.
Article
in English
| MEDLINE | ID: mdl-33015030
16.
Docetaxel in the management of head and neck cancer.
Anticancer Drugs
; 20(8): 639-45, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19639668
17.
Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: Outcome analysis in 93 patients treated in a single institution.
Oral Oncol
; 92: 77-84, 2019 05.
Article
in English
| MEDLINE | ID: mdl-31010628
18.
Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy.
Future Sci OA
; 5(1): FSO347, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30652016
19.
Phase II study of rubitecan in recurrent or metastatic head and neck cancer.
Cancer Chemother Pharmacol
; 62(2): 209-14, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-17882418
20.
The proteasome: a worthwhile target for the treatment of solid tumours?
Eur J Cancer
; 43(7): 1125-33, 2007 May.
Article
in English
| MEDLINE | ID: mdl-17379504